261G000462 - Adalimumab 40 mg/0,4 ml sol inj biossimilar caneta
TED · 325619-2026Award noticeawardedNo deadline given
Value
Estimated€396,644 · 396,644 EUR
Awarded€396,644 · 396,644 EUR
WinnerAMGEN BIOFARMACEUTICA, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 35 | — | 2026-10-27 |
| GILEAD SCIENCES, LDA | 32 | — | 2026-11-03 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 25 | €1,569,649 | 2026-11-03 |
| JANSSEN-CILAG FARMACEUTICA LDA | 19 | €371,730 | 2026-10-13 |
| NOVARTIS FARMA - PROD.FARM SA | 19 | — | 2026-10-20 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33650000 Medical equipment & pharmaceuticalsDescription
Adalimumab 40 mg/0,4 ml sol inj biossimilar caneta
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-11-05 | AD/2999/2026 Aquisição de Adalimumab 40 mg/0.4 ml Sol inj Caneta 0.4 ml SC (biossimilar), para a ULSTMAD, EPE | Unidade Local de Saúde de Trás-os-Montes e Alto Douro, EPE PT | 95% |
| 2026-07-21 | 261G000791 - BINIMEtinib 45 MG COMP | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-05-05 | 261G000262 - IMIglucerase INJ 400 UI | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-07-21 | 2024/0899 - MEPOLIZUMAB [100 MG/1 ML SOL INJ CANETA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-10-27 | 2026/0006 - NIVOLUMAB [10 MG/ML 4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-08-04 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |